Evidence map›Paper›PMID 40401238›Full record

ArticleInternational journal of biochemistry and molecular biology2025

Hepatoprotective and antioxidant effects of

Tunbosun Emmanuel Akinboboye, Temitope Deborah Olaniyi, Gbadebo E Adeleke, Abiodun Bukunmi Aborisade, Adewale Adetutu

Abstract read
In one paragraph

Article in International journal of biochemistry and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tunbosun Emmanuel AkinboboyeDepartment of Biochemistry, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.
Temitope Deborah OlaniyiDepartment of Biochemistry, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.
Gbadebo E AdelekeDepartment of Biochemistry, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.
Abiodun Bukunmi AborisadeDepartment of Biochemistry, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.
Adewale AdetutuDepartment of Biochemistry, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParacetamol is a widely used over-the-counter drug for pain relief and fever management. However, its misuse through chronic overuse or acute overdose presents significant risks to human health, primarily causing hepatotoxicity and systemic oxidative stress. METHODOLOGY: This study evaluated the hepatoprotective, antioxidant, and anti-inflammatory effects of aqueous leaf extracts of

resultsParacetamol administration (150 mg/kg) significantly elevated liver function markers (ALT, AST, ALP, and bilirubin), oxidative stress parameters (MDA), and inflammatory cytokines (IL-6 and TNF-α), while depleting antioxidant defenses (SOD and GSH). Disrupted lipid profiles were also observed in the paracetamol-only group. Pretreatment with Celosia trigyna and Euphorbia hirta extracts (125 mg/kg and 250 mg/kg) effectively ameliorated these effects by normalizing liver function markers, reducing oxidative stress and inflammation, and restoring lipid profiles. Molecular docking identified bioactive compounds such as rutin, quercetin, and kaempferol as potent inhibitors of Glutathione-S-Transferase, Tumor Necrosis Factor-alpha, and Cytochrome P450, with binding affinities of -9.3, -7.2, and -8.3 kcal/mol, respectively. These interactions underpin the antioxidant and anti-inflammatory activities observed

conclusionThese findings suggest that

Indexed as

and hepatoprotective agentsCelosia trigynaEuphorbia hirtainflammationoxidative stressParacetamol-induced hepatotoxicity

Identifiers

PMID40401238
PMCPMC12089789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.